Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT)
| dc.contributor.author | Mundle, S. | |
| dc.contributor.author | Li, S. | |
| dc.contributor.author | Luna, Y. | |
| dc.contributor.author | Chi, K. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Woo, H. | |
| dc.contributor.author | Fizaz, K. | |
| dc.contributor.author | Sulur, G. | |
| dc.contributor.author | Tran, N. | |
| dc.contributor.author | Fein, L. | |
| dc.contributor.author | Matsubara, N. | |
| dc.contributor.author | Rodriguez-Antolin, A. | |
| dc.contributor.author | Alekseev, B. | |
| dc.contributor.author | Ye, D. | |
| dc.contributor.author | Feyerabend, S. | |
| dc.contributor.author | Protheroe, A. | |
| dc.date.accessioned | 2021-03-02T22:01:10Z | |
| dc.date.available | 2021-03-02T22:01:10Z | |
| dc.identifier.citation | Woo H., Fizaz K., Sulur G., Tran N., Fein L., Matsubara N., Rodriguez-Antolin A., Alekseev B., Ozguroglu M., Ye D., et al., "Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT)", Annual Scientific Meeting of the Urological-Society-of-Australia-and-New-Zealand, Brisbane, Avustralya, 13 - 16 Nisan 2019, cilt.123, ss.27-28 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_0a36b8bf-1d97-4a47-9742-01301f6e0d58 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/12622 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Nefroloji | |
| dc.subject | ÜROLOJİ VE NEFROLOJİ | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.title | Final analysis of phase 3 LATITUDE study in patients (pts) with newly diagnosed high-risk metastatic castration-naive prostate cancer (NDx-HR mCNPC) treated with abiraterone acetate plus prednisone (AA plus P) added to androgen deprivation therapy (ADT) | |
| dc.type | Bildiri | |
| dc.contributor.department | University Of Sydney , , | |
| dc.identifier.volume | 123 | |
| dc.contributor.firstauthorID | 155921 |
Files in this item
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||
This item appears in the following Collection(s)
-
Bildiri [64839]